Introduction
The classical theory on the cellular effects of ionizing radiation identifies DNA as the direct target for initiating death pathways (Radford, 1986; Ward, 1988) . DNA double-strand breaks (DSBs) are lethal lesions, and unrepaired or misrepaired breaks lead to mitosis-associated (also termed reproductive or postmitotic) cell death or to P53-mediated apoptosis. The coordinated function and fidelity of constitutively expressed or induced pathways of DNA damage recognition and repair, and of cell cycle control pathways, determine the level of cellular sensitivity to the lethal effects of radiation (Abraham, 2001; Norbury and Hickson, 2001; Bernstein et al., 2002; Jackson, 2002) . The recent emergence of the sphingomyelin pathway as a mediator of radiation-induced apoptosis (Fuks et al., 1995b; Pena et al., 1997) provides an alternative to this model. Studies by Haimovitz-Friedman et al. (1994b) demonstrated that radiation targets the cell membrane of bovine aortic endothelial cells to induce activation of sphingomyelinase, a sphingomyelin-specific form of phospholipase C, which generates ceramide by enzymatic hydrolysis of the phosphodiester bond of sphingomyelin. Ceramide then acts as a second messenger in initiating an apoptotic response. Sphingomyelin is a phospholipid localized mainly at the outer leaflet of the plasma membrane, where it provides a semipermeable barrier to the extracellular environment (Kolesnick, 1991) . In 1987, Kolesnick reported that 1,2-diacylglycerols induces sphingomyelinase activation in GH3 pituitary cells (Kolesnick and Paley, 1987) and suggested for the first time that this response may activate a sphingomyelin-based signaling pathway (Kolesnick and Clegg, 1988; Kolesnick, 1989) . Subsequently, Okazaki et al. (1989 Okazaki et al. ( , 1990 confirmed this notion, demonstrating that receptor binding of vitamin D 3 induced sphingomyelinase activation and that the generated ceramide served as a second messenger in a differentiation pathway of HL-60 cells. Over the past decade, ceramide and other sphingolipids have been identified as primary regulators of signal transduction involved in multiple biological functions (Mathias et al., 1998; Hannun et al., 2001) . More recently, radiation-induced activation of the sphingomyelin pathway has attracted increasing attention, as several studies reported its engagement as a primary event in the pathogenesis of radiation damage to several normal tissues. Here, we review the biochemical pathways of radiation-induced ceramide generation, its involvement in apoptotic signaling, and its role in the evolution of radiation-induced tissue damage in vivo. Whereas this pathway can be modulated, we also describe the potentials for development of ceramidebased therapies in the management of human cancer.
Biochemical pathways of ceramide generation
Sphingolipids consist of a backbone of a long-chain sphingoid base, an amide-linked long-chain fatty acid, and a polar head group, which defines the sphingolipid subtype (Spiegel et al., 1996) . A hydroxyl head group is found in ceramide, phosphorylcholine in sphingomyelin, and carbohydrates in glycosphingolipids (Spiegel et al., 1996; Merrill et al., 1997) . Figure 1 shows a schematic representation of sphingolipid intermediary metabolism. Ceramide is generated by enzymatic hydrolysis of sphingomyelin via activation of sphingomyelinase (SMase) or by de novo synthesis coordinated through the enzyme ceramide synthase (CS) (Spiegel et al., 1996; Merrill et al., 1997; Mathias et al., 1998; Hannun et al., 2001) . There are several isoforms of SMase, distinguished by pH optima for their activity, and hence referred to as acid (ASMase), neutral (NSMase) or alkaline SMase. The pH optima appear to regulate the on-off rate of substrate rather than the catalytic activity of the enzyme (Schissel et al., 1998a) . Consistent with this notion, it was reported that when sphingomyelin is presented in LDL particles, it is hydrolyzed by ASMase even at neutral pH (Schissel et al., 1996) . Both NSMase and ASMase are rapidly activated by diverse stress stimuli, including UV and ionizing radiation, leading to an increase of ceramide levels in a time frame of minutes to hours (Mathias et al., 1998; Hannun et al., 2001) . Alkaline SMase activity is found in the intestinal mucosa and bile and does not appear to participate in signal transduction (Duan et al., 1996) . Both mammalian ASMase and NSMase have been cloned (Schuchman et al., 1991 (Schuchman et al., , 1992 Hannun et al., 2001; Marchesini et al., 2003) , and their genes have been shown to be distinct. Accordingly, ASMase knockout mice show normal NSMase activity (Horinouchi et al., 1995) .
Acid SMase plays a critical role in mediating radiation-induced endothelial apoptosis both in vitro and in vivo (Haimovitz-Friedman et al., 1994b; Santana et al., 1996) . While originally described as a lysosomal enzyme (pH optimum 4.5-5.0) defective in patients with Niemann-Pick disease (Schneider and Kennedy, 1967) , a secretory isoform has been recently reported, which targets the plasma membrane, and is secreted extracellularly (Schissel et al., 1998a, b) . Although originating from the same inactive 75 kDa precursor, the lysosomal and secretory ASMase forms are differentially processed at the NH 2 -terminus and display a different glycosylation pattern (Schissel et al., 1996 (Schissel et al., , 1998a , which likely determines the targeting of ASMase. The secretory form of ASMase functions in the hydrolysis of cell surface sphingomyelin to initiate signaling (Schissel et al., 1996) . The vulnerability of the endothelium to radiationinduced apoptosis appears related to the high levels of ASMase expression in endothelial cells, which is approximately 20-fold higher than in macrophages (Marathe et al., 1998) , and to its preferential trafficking to the plasma membrane.
Neutral ASMase has also been implicated in the radiation response (Bruno et al., 1998; Chmura et al., 2000; Jaffrezou et al., 2001; Rodriguez-Lafrasse et al., 2002) . Its activity (pH optimum 7.4) can be inhibited by glutathione and is, therefore, de-repressed under conditions of oxidative stress, when glutathione is depleted (Liu et al., 1998) . Agents such as TNF-a, which induce this state, lead to prolonged ceramide generation (Liu et al., 1998) . Free fatty acids may enhance NSMase activity (Jayadev et al., 1994) , and conditions that increase free fatty acid levels, such as might occur in the GI tract upon treatment with cyclooxygenase inhibitors, increase NSMase activity (Chan et al., 1998) . Activation of NSMase by TNF critically depends on FAN (for factor associated with NSMase activation) (AndrieuAbadie and Levade, 2002), a protein reported to interact with the intracellular domain of TNF receptor (AdamKlages et al., 1996) . Studies using truncated mutants of the cytoplasmic domain of the 55-kDa TNF receptor (TNFR-55) have identified a cytoplasmic region (designated NSD, for neutral SMase activation domain) of this receptor, which is distinct from the death domain and contains a small sequence of 10 amino-acid residues that is necessary for activation of NSmase . The role of FAN in TNF signaling has been confirmed on cells derived from FAN knockout mice, which display defects in ceramide generation and apoptosis (Kreder et al., 1999) .
Involvement of de novo biosynthesis of ceramide in the radiation response has recently been reported by Liao et al. (1999) . This pathway requires coordinated activity of serine palmitoyl transferase and CS (Spiegel et al., 1996; Hannun et al., 2001; Merrill et al., 1997) . It begins with condensation of serine and palmitoyl-CoA to form 3-ketosphinganine, which is reduced to the sphingoid base sphinganine and acylated by CS to yield dihydroceramide This compound is oxidized to ceramide by introduction of a trans-4,5 double bond, thus converting the sphinganine moiety to sphingosine (Merrill et al., 1997; Hannun et al., 2001) . Under normal conditions, ceramide synthesis occurs in the endoplasmic reticulum, providing the basic unit for synthesis of more complex sphingolipids (Mandon et al., 1992) . CS is also found in mitochondria (Mandon et al., 1992; Shimeno et al., 1995) , where it may to be activated by stress stimuli, such as phorbol ester, daunorubicin and radiation (Bose et al., 1995; Garzotto et al., 1998 Garzotto et al., , 1999 Liao et al., 1999) , resulting in delayed ceramide elevation developing within hours to days.
Ceramide metabolism
Once generated, ceramide may amass or be converted into a variety of metabolites (Figure 1 ). Phosphorylation by ceramide kinase generates ceramide 1-phosphate (Mathias et al., 1998) , while deacylation by ceramidases yields sphingosine, which may be phosphorylated by sphingosine kinase to sphingosine-1-phosphate (S 1-P) (Li et al., 2002) . Ceramide may also be converted back to sphingomyelin by transfer of phosphorylcholine from phosphatidylcholine to ceramide via sphingomyelin synthase (Mathias et al., 1998) . Ceramide can also be glycosylated by glucosylceramide synthase to form glucosylceramide, which may be further modified to form complex glycosphingolipids by various enzymes of the Golgi apparatus. The metabolic products of ceramide may serve as effector molecules, often inducing proliferation, but with the exception of sphingosine and GD 3 they do not appear to signal apoptosis (Spiegel and Kolesnick, 2002) . Further, some cells manifest an enhanced conversion of ceramide to nonapoptotic or antiapoptotic derivatives, apparently altering the balance between apoptosis and proliferation, and thus provide a mechanism for resistance to radiation-induced apoptosis (Kolesnick, 2002; Spiegel and Kolesnick, 2002) .
Ceramide as a second messenger regulating stress responses
Although ceramide has been shown to signal diverse events, such as differentiation, senescence, proliferation and cell cycle arrest (Kolesnick and Hannun, 1999; Kolesnick, 2002; Luberto et al., 2002) , a large body of research has focused on its role in stress responses (Lin et al., 2000; Gulbins and Kolesnick, 2002; Kolesnick, 2002; Pettus et al., 2002) . Evidence supporting ceramide as a message for stress-induced apoptosis is based on data from many cell systems that demonstrate an increase in ceramide levels preceding biochemical and morphologic manifestations of apoptosis. Addition of natural ceramide, SMase, or pharmacologic agents, which interfere with enzymes of ceramide metabolism, mimic the effects of stress on apoptosis induction. Finally genetically deficient models of ceramide generation (NPD cells, asmase À/À mice, FAN À/À mice and yeast mutants) manifest abnormalities in stress-induced apoptosis (Kreder et al., 1999; Lin et al., 2000; Gulbins and Kolesnick, 2002; Kolesnick, 2002; Luberto et al., 2002; Pettus et al., 2002) . Recent work indicates that ceramide is an evolutionarily conserved stress response signal, obligate for heat adaptation in Saccharomyces cerevisiae (Dickson et al., 1997; Jenkins et al., 1997) . Mutants incapable of rapid de novo synthesis of this sphingolipid upon heating do not adapt and grow at elevated temperatures (Wells et al., 1998) . This defect is bypassed by exogenous sphingolipid, confirming an obligate requirement for ceramide in this response. Thus, ceramide signaling may constitute a programmed stress response that predates apoptosis evolutionarily.
Cellular targets for ceramide signaling
Ceramide was reported to interact directly with elements of several signaling pathways, including kinase suppressor of RAS (KSR; identical to ceramide-activated protein kinase) (Zhang et al., 1997; Yan and Polk, 2001) , ceramide-activated protein phosphatase (CAPP) , protein kinase C (Kashiwagi et al., 2002) , c-RAF-1 (Huwiler et al., 1996; Zhou et al., 2002) , the small G proteins RAS and RAC (Gulbins et al., 1995; Brenner et al., 1997) , phospholipase A 2 and cathepsin D (Huwiler et al., 2001) . The mechanisms of ceramide interaction with these targets are not completely known. It was shown to bind directly to cathepsin D (Huwiler et al., 2001) , triggering autocatalytic cleavage of cathepsin to its active form (Deiss et al., 1996) . A recent report by Kashiwagi et al. (2002) demonstrated that ceramide binds to the C1B domain of PKCd in COS7 and CHO-K1 cells, directing its translocation to the intracellular membrane compartments. Ceramide exhibited a high affinity towards the C1B domain, exceeding the binding affinity of the phorbol ester TPA. Interestingly, other ceramideresponsive factors, such as KSR and c-RAF-1, contain C1B domains; however, whether the C1B domain targets these proteins to sites of ceramide generation, such as plasma membrane rafts, is presently unknown. Ceramide also indirectly activates the Src-like tyrosine kinase p56lck that blocks the n-type K þ channel (n-K þ , Kv1.3) and calcium releaseactivated calcium channel (CRAC) (Lepple-Wienhues et al., 1999) in lymphocytes, the c-Jun N-terminal kinases (JNKs) to signal apoptosis in a variety of cells (Westwick et al., 1995; Verheij et al., 1996) , and BAD Radiation and ceramide-induced apoptosis R Kolesnick and Z Fuks via a pathway involving RAS, KSR, c-RAF-1, and MEK-1 (Basu et al., 1998) . Stimulation of the latter pathway results in AKT inactivation. Since the kinase activity of AKT maintains Bad in the inactive form, inhibition of AKT in turn releases BAD and, finally, permits BAD-triggered cell death. The above data support ceramide as a classic second messenger, presumably activating target proteins stoichiometrically. Recently, a new mechanism for ceramide function has been identified based on its biophysical effects on membrane bilayers (Cremesti et al., 2002; Gulbins and Grassme, 2002) . Stimulation of CD95 or CD40 with the cognate ligand resulted in translocation of the secretory form of ASMase onto the outer leaflet of the plasma membrane (Cremesti et al., 2001; Grassme et al., 2001 Grassme et al., , 2002 . Surface ASMase, now in the proximity of sphingomyelin at the outer plasma membrane, releases ceramide within glycosphingolipidenriched microdomains (GEMs) (also known as rafts). These rafts are originally formed in the Golgi apparatus and are targeted to the plasma membrane, where they exist as floating islands within the bulk membrane (Simons and Ikonen, 2000) . It is estimated that as much as 70% of all cellular sphingomyelin may be found in rafts (Prinetti et al., 2001) . Accumulation of ceramide in rafts results in their reorganization into larger platforms . This response is consistent with the capacity of ceramide to spontaneously self-associate via hydrogen bonding and perhaps van der Waal interactions, and the ability of these aggregates to coalesce into larger platforms . The functional significance of this reorganization of membrane structure is that it appears to facilitate signaling by promoting protein oligomerization. Indeed, preformed FAS trimers localize to these domains and appear to form higher-order multimers, allowing for FAS to signal oligomerization of the downstream effectors FADD/MORT-1 and caspase-8 on the cytoplasmic surface of FAS (Chmura et al., 2001; Gajate and Mollinedo, 2001; Hueber et al., 2002) . Hence, in addition to facilitating transactivation of clustered receptors, these signaling platforms may stabilize their interaction with ligands and recruit intracellular signaling molecules to the activated receptors . Activation of apoptotic signaling by ceramide generated in rafts has been recently demonstrated for P13K (Zundel and Giaccia, 1998) . These studies identified ASMase-and ceramidedependent recruitment of caveolin 1 to P13K-receptor complexes within rafts, which blocked the activity of P13K. Raft aggregation into platforms may also be involved in nonreceptor-mediated signaling. For instance, UVC triggers aggregation of cell surface CD95 (Rehemtulla et al., 1997) , which might be sufficient to initiate signaling of CD95 at least under stress conditions. Recent experiments have suggested that raft aggregation may be involved in UV and ionizing radiation induction of ceramide-mediated apoptosis, without involving CD95 (Kolesnick, unpublished) . Raft disintegration by cholesterol depletion aborted these responses.
Ceramide and radiation-induced cell death
While the p53-mediated pathway is the most acclaimed mechanism of radiation-induced apoptosis (Lowe et al., 1993) , a large body of data has accumulated over the past decade establishing ceramide as a second messenger in mediating radiation-induced apoptosis in specific systems in vitro and in vivo (Pena et al., 1997; Mathias et al., 1998; Lin et al., 2000) . Figure 2 shows a schematic representation of pathways of radiation-induced apoptosis. Haimovitz-Friedman et al. (1994b) provided the initial data indicating that radiation damage to the plasma membrane might initiate apoptotic signaling through ceramide. Irradiation of bovine aortic endothelial cells (BAEC) induced sphingomyelin conversion to ceramide within seconds and apoptosis, and analogs of ceramide, but not other potential second messengers, mimicked the effect of radiation to signal apoptosis (Haimovitz-Friedman et al., 1994b) . Foremost, radiation stimulated the generation of ceramide in isolated membranes devoid of nuclei, suggesting that ceramide generation occurred without DNA damage. The enzymes involved in radiation-induced ceramide generation may be cell type specific. Chmura et al. (1997b) and Bruno et al. (1998) reported that radiation activated NSMase in lymphoid WEHI-231 and TF-1 human myeloid leukemia cells, while Zundel and Giaccia (1998) and Bohler et al. (1997) found ASMase activation in Rat-1 Myc-ER cells and primary skin fibroblasts. Santana et al. (1996) showed ASMase activation in human B lymphoblastoid cells and in lung endothelium. In SQ-20B human head and neck squamous cells, both NSMase and ASMase appeared involved in the radiation response (Chmura et al., 1997b) . Radiation-induced DNA damage was shown to signal ceramide generation via activation of CS in HeLa cells . Definitive evidence for the causative role of ceramide in radiation-induced apoptosis has been derived from a series of genetic studies with ASMase-deficient models. B lymphoblastoid cells immortalized from a patient with type I NPD, which exhibited no ASMase activity but had normal NSMase activity, failed to degrade sphingomyelin in response to radiation, generate ceramide or undergo apoptosis (Santana et al., 1996) . Retroviral transfer of normal ASMase cDNA to these cells restored both ceramide generation and apoptosis upon irradiation. Similarly, embryonic fibroblasts (MEFs) from the ASMase knockout (asmase À/À ) mice failed to generate ceramide and were totally resistant to radiation-induced apoptosis, but remained sensitive to staurosporineinduced apoptosis, which is not mediated via ceramide signaling (Lozano et al., 2001 ). Sensitivity to radiationinduced apoptosis could be restored in these MEFs by preradiation treatment with minute amounts of natural ceramide, which by itself does not induce cell death. The ability to overcome apoptosis resistance by natural ceramide is evidence that lack of ceramide, and not ASMase, determines the resistance to radiation-induced apoptosis. Rescue of the apoptotic phenotype by the product of the enzymatic deficiency, without reversing the genotype, provides definitive proof that ceramide is obligate for apoptosis induction in response to radiation in some cell types.
X-irradiation
Recent studies have also provided mechanistic insights into signaling of radiation-induced apoptosis via ceramide. In BAEC and U937 cells, stress-induced ceramide (oxidative, UV, ionizing radiation, heat, cytokines) activated the JNK system and apoptosis, while dominant negative kinases of the JNK cascade blocked apoptosis in response to radiation or exogenous ceramide (Verheij et al., 1996) . Pretreatment of BAEC with basic fibroblast growth factor inhibited signaling via this pathway (Verheij et al., 1996) , apparently by abolishing radiation-induced ceramide generation via ASMase (Haimovitz-Friedman, unpublished) . In Rat-1 Myc-ER cells, the ceramide induced in response to stress (ultraviolet C, ionizing radiation, hyperosmolarity) coupled phosphoinositide 3 0 -kinase (PI3K) to caveolin-1 conferring PI3K inactivation (Zundel and Giaccia, 1998) . Since PI3K normally provides sustained antiapoptotic signaling in several mammalian cells, its inactivation promoted an apoptotic response to stress. Further, exogenous ceramide mimicked the radiation effect to inactivate PI3K, and cells from NPD patients were deficient in radiation-induced ceramide generation, PI3K inactivation and apoptosis. Tepper et al. (1999) provided additional data on the molecular ordering of ceramide signaling in response to radiation. In Jurkat cells, CD95 (FAS/APO-1), radiation or etoposide-induced ceramide generation and apoptosis, while a clone resistant to CD95 resulted in cross-resistance to ionizing radiation and etoposide. Ceramide analogs bypassed the resistance, while BCL-2 inhibited the apoptotic response in the wild-type cells. Whereas other studies reported that BCL-2 does not block ceramide generation upon stress Susin et al., 1996; Decaudin et al., 1997) , these studies order ceramide downstream of radiation and upstream of mitochondrial regulation of apoptosis. Further evidence on the engagement of BAX downstream of ceramide was derived from studies by Liao et al. (1999) and Lee et al. (2003) . These studies showed that radiation-induced DNA damage signals activation of CS, de novo synthesis of ceramide and apoptosis. DNA DSBs were induced in BAEC and HeLa cells by external irradiation or via metabolic incorporation of 125 I-labeled 5-iodo-2 0 -deoxyuridine. CS activation and ceramide generation occurred within the mitochondria, but not the endoplasmic reticulum. Activation of CS was obligatory for signaling apoptosis, since FB1, a specific fungal CS inhibitor, abrogated DNA damageinduced death. The ceramide generated regulated integration of BAX into the outer mitochondrial membrane, cytochrome c release and caspase-3 activation, events that were inhibited by preradiation treatment with FB1. Mitochondria isolated from unirradiated cells that had been pretreated with highdose FB1 displayed depletion of ceramide, resisted BAX integration and did not release cytochrome c in response to exogenous BAX, while addition of exogeneous ceramide restored the ability to respond to BAX.
The studies by Liao et al. (1999) also showed that the ataxia telangiectasia-mutated (ATM) gene product regulates the apoptotic pathway activated by radiation-induced DNA damage. EBV-immortalized B cell lines derived from six ataxia telangiectasia (AT) patients with different mutations of the ATM gene exhibited proficient radiation-induced CS activation, ceramide generation and apoptosis, whereas three lines from normal patients failed to manifest these responses. Stable transfection of wild-type ATM cDNA reversed the response of the ATM cells, while antisense inactivation of ATM in normal B cells conferred the AT phenotype. These data provided evidence that signals from DNA damage and ATM can reciprocally regulate the CS activity and the proclivity to apoptosis upon radiation exposure.
Pharmacologic modulation of the ceramide response to radiation can predictably affect ceramide levels and sensitivity to apoptosis induction. Weichselbaum and co-workers selected a population of WEHI-231 cells by long-term incubation with increasing concentrations of the acid ceramidase inhibitor N-oleoylethanolamine (Chmura et al., 1997b) . This manipulation selected a WEHI-231 population that exhibited acquired resistance to SMase-mediated apoptosis in response to radiation. Recently, Gelmann and co-workers found that human LNCaP prostate cancer cells did not respond to 8 Gy with ceramide generation or apoptosis, whereas they were minimally responsive to the apoptotic effect of TNF-a (Kimura et al., 1999) . However, the combination of 8 Gy and TNF-a resulted in synergistic ceramide elevation and apoptosis. Further, ceramide analogs at doses that did not induce apoptosis replaced TNF-a, yielding synergistic apoptosis in combination with 8 Gy. Another approach to modulate the apoptosis resistance of LNCaP cells was reported by Garzotto et al. (1998 Garzotto et al. ( , 1999 . Modulation of CS activity by TPA (12-O-tetradecanoylphorbol acetate) modulated the response of prostate cancer cells to the effects of radiation. While in most cell types tested, TPA signaled antiapoptosis via activation of PKC (Haimovitz-Friedman et al., 1994a, b) , in LNCaP cells, TPA was found to induce moderate apoptotic response via activation of CS (Garzotto et al., 1999) . Pretreatment with TPA enabled radiation to significantly enhance ceramide generation via CS activation and resulted in a synergistic apoptotic response -events inhibited by FB1. Furthermore, when transplanted orthotopically into the prostate of nude mice, LNCaP cells produced tumors that recapitulated the responses of LNCaP cells in vitro. Radiation or TPA failed to signal apoptosis in LNCaP tumors, whereas a combination of the two resulted in substantial (20-25%) apoptosis within 24 h. There was an additional benefit associated with this regimen because TPA pretreatment protected the adjacent rectum from radiation-induced apoptosis. Taken together, these studies suggest that modulators of ceramide metabolism may alter the balance between ceramide generation and its removal, thereby influencing radiation-induced apoptotic signaling and its pathologic consequences.
Several investigators have reported that protein kinase C (PKC) modulation affects the apoptotic response to radiation (Haimovitz-Friedman et al., 1994a, b) . In this context, studies have shown that radiation may activate PKCa via diacylglycerol (DAG) generation (Chmura et al., 1996 (Chmura et al., , 1997a Bruno et al., 1998) . As mentioned above, activation of PKC by phorbol esters blocked in most cell types tested radiation-induced ceramide generation and apoptosis (Haimovitz-Friedman et al., 1994a, b; Santana et al., 1995; Chmura et al., 1996; Allan-Yorke et al., 1998; Bruno et al., 1998) . Conversely, pharmacologic inhibition of PKC enhanced radiation-induced cell death (Hallahan et al., 1992b) . The mechanism by which TPA and DAG inhibit apoptosis apparently via inhibition of SMase activation (Santana et al., 1995) ; in some cells, this may occur through upregulation of BCL-2 or BCL-XL (Hallahan et al., 1992a; Uckun et al., 1993) . bFGF similarly protected endothelial cells against radiationinduced apoptosis, in part via activation of the PKC and MAPK pathways (Haimovitz-Friedman et al., 1994a; Verheij et al., 1996) , but also via inhibition of SMasemediated generation of ceramide (Haimovitz-Friedman, unpublished) .
Involvement of ceramide in radiation-induced tissue damage in vivo
Similar to observations made in vitro, radiation was shown to induce ceramide-mediated endothelial cell apoptosis in several organs in vivo, including the alveolar septi of the lung (Fuks et al., 1995a; Santana et al., 1996) , the intestinal mucosa ) and the central nervous system (Pena et al., 2000) . Histopathological studies showed that the damage to the endothelium was confined to the microvasculature, while larger vessels appeared resistant to this effect. Endothelial apoptosis developed as an early event after exposure, peaking at 4-10 h after irradiation and was dose dependent. A maximal apoptotic effect was observed in the intestinal mucosa at 15 Gy, in the lung at 25 Gy and the CNS at 40 Gy (Fuks et al., 1995b; Santana et al., 1996; Paris et al., 2001; Pena et al., 2000) . Measurements of ceramide kinetics in tissue extracts of the lung revealed that apoptosis was preceded by ceramide elevation, which reached a maximal two-fold of control by 15 min after 10 Gy (Santana et al., 1996) . Evidence that ASMase activation is obligatory for this response was derived from studies with the asmase À/À mice (Figure 3) , which demonstrated abrogation of ceramide generation and apoptosis in the endothelium of the lung and intestines and brain after whole body radiation (Santana et al., 1996; Pena et al., 2000; Paris et al., 2001) . These animals, however, displayed normal P53-mediated apoptosis in the thymus. In contrast, P53 À/À mice manifested normal ceramide generation and apoptosis in the lung and intestines, while thymic apoptosis was abolished, indicating that the p53 and sphingomyelin pathways of radiation-induced apoptosis are distinct and independent. Intravenous treatment with bFGF inhibited ceramide generation and aborted the endothelial apoptotic response in the intestines, brain and lung of wild-type mice (Santana et al., 1996; Haimovitz-Friedman et al., 1997; Pena et al., 2000; Paris et al., 2001) , consistent with bFGF inhibition of SMasemediated ceramide generation and apoptosis in irradiated endothelial cells in vitro (Haimovitz-Friedman et al., 1994a, b; Fuks et al., 1995b) .
Evidence for relevance of the microvascular apoptotic response to induction of tissue damage by radiation was derived from the genetic and pharmacologic studies with the intestinal and lung models. These studies suggested that the microvascular endothelium serves as the primary target for radiation in the induction of tissue damage, challenging the notion that tissue stem cells are the direct targets. Whole-body irradiated C 57 BL/6 mice receiving 10-13 Gy were shown to die at 10-13 days with intact gastrointestinal (GI) tract and depleted bone marrow (BM), while mice irradiated with 15 Gy died at 671 day with denuded GI mucosa and moderately damaged marrow . TUNEL staining of tissue specimens showed apoptosis in the crypt/villus microvasculature at 4 h, increasing in severity with dose, and the risk of death from the GI syndrome correlated with the incidence of severe endothelial apoptosis. Intravenous bFGF inhibited the induction of endothelial apoptosis and prevented radiation-induced crypt damage, organ failure and GI death. Abrogation of severe apoptosis and protection against death from the GI syndrome was also noted in asmase À/À mice treated with doses X15 Gy. In situ hybridization showed that endothelial cells, but not epithelial crypt cells, expressed high affinity receptors for bFGF, ordering the endothelial lesion upstream of crypt stem cell damage in the evolution of the GI syndrome. Consistent with this notion, intravenous bFGF was shown to protect C3H/ HeJ mice against lethal radiation pneumonitis, increasing the LD 50/180 from 20.75 Gy to 23.0 Gy (Fuks et al., 1995a) . Further, studies of experimental LPSinduced septic shock, which like WBR causes GI death via microvascular endothelial apoptosis, revealed that ASMase deficiency or intravenous bFGF inhibited stress-induced ceramide elevation in extracts of the GI mucosa, aborted GI microvascular endothelial apoptosis and protected against denudation of the GI mucosa, thereby rescuing the animals from septic shock and death (Haimovitz-Friedman et al., 1997) .
Another organ in which abrogation of ASMasemediated apoptosis results in prevention of radiationinduced damage and in preservation of organ function is the ovary of fertile female mice. Tilly and co-workers showed that asmase À/À mice are defective in the normal apoptotic deletion of fetal oocytes during embryogenesis, leading to neonatal ovarian hyperplasia (Morita et al., 2000) . Ex vivo, oocytes from asmase À/À mice, or wild-type oocytes treated with sphingosine-1-phosphate (S1P), a ceramide metabolite known to inhibit ceramidemediated apoptosis (Kolesnick, 2002; Spiegel and Kolesnick, 2002) , resisted apoptosis induced by daunorubicin, confirming cell autonomy of the death defect (Morita et al., 2000) . BAX was found to function downstream of ceramide in this pathway (Morita et al., 2000) . Low-dose radiation (0.1 Gy) induced 90% loss of oocytes and infertility in adult wild-type female mice and was abrogated by in vivo therapy with S1P. Further, oocytes superovulated from S1P-pretreated and irradiated animals yielded normal blastocysts after in vitro fertilization, while oocytes from vehicle-treated animals generated defective blastocysts, indicating that oocytes preserved by S1P retained normal function, at least in the short-term (Morita et al., 2000) .
To evaluate whether oocyte protection by S1P resulted in long-term preservation of ovarian function and fertility, mating trials were carried out between normal male C57BL/6J mice and females treated 2 months earlier with intrabursal injection of S1P and 0.1 Gy ovarian irradiation. Only 50% of vehicle-treated irradiated females delivered litters during the first mating trial, which dropped to 12.5% by the fourth trial. In contrast, all S1P-treated and irradiated females displayed normal delivery rates initially, and after 1 year 75% remained fertile . Critically, this preservation of fertility was accomplished without propagating genetic damage in offspring of the S1P-protected females . Thus, S1P may represent the first agent capable of protecting the fertile female against premature ovarian failure resulting from ovarian exposure to ionizing radiation.
Conclusions
Over the past few years, there has been an escalating interest in the role of ceramide and its metabolites in Figure 3 Radiation-induced endothelial apoptosis is ASMase-dependent and p53-independent. Tissue specimens were obtained from mice at 4-10 h after exposure to whole-body irradiation at the indicated doses and TUNEL stained for detection of apoptosis as described (Santana et al., 1996; Pena et al., 2000; Paris et al., 2001) . Brown nuclei are indicative of apoptosis Radiation and ceramide-induced apoptosis R Kolesnick and Z Fuks tissue physiology and pathophysiology. Levels of ceramide can be manipulated by various biological response modifiers and drugs. In this context, the observation that several transformed cell systems are hypersensitive to the effects of ceramide perturbation suggests strategies to enhance tumor cell killing by increasing their ceramide content. The generality of this paradigm must still be tested in studies of many more normal and tumor cell types. Other approaches to modulation of the ceramide pathway are also feasible in vivo, but for it to be of clinical value, it will be necessary to define specific responses to these messages in live tissue. Hence, advancement in defining sphingolipiddependent signaling pathways, derived from establishing a large body of biochemical, genetic and physiological data, may provide new targets for modulation of the radiation response with important potential for clinical application.
